873537-27-0

Usage

Uses

Used in Pharmaceutical Industry:
4-(4-Ethyl-1-piperazinyl) is used as a key component in the development of various pharmaceutical products for its potential therapeutic applications.
Used in Antipsychotic Drugs:
4-(4-Ethyl-1-piperazinyl) is used as an active ingredient in antipsychotic medications, helping to manage symptoms of mental disorders by targeting specific receptors in the brain.
Used in Antihistamines:
4-(4-Ethyl-1-piperazinyl)... is used as a constituent in antihistamine formulations, aiming to alleviate allergic reactions by blocking the action of histamine, a chemical responsible for allergy symptoms.
Used in Antiemetics:
4-(4-Ethyl-1-piperazinyl) is used as a component in antiemetic drugs, which are designed to prevent or treat nausea and vomiting by influencing the central nervous system.
Used in Sedatives:
4-(4-Ethyl-1-piperazinyl)... is utilized in the formulation of sedative medications, intended to induce a calming effect and help with sleep or anxiety management.

Upstream product

• 694501-34-3 1-ethyl-4-(2-fluoro-4-nitro-phenyl)-piperazine 
• 5308-25-8 4-ethylpiperazine 
• 369-34-6 3,4-difluoronitrobenzene 

Downstream Products

• 1239875-70-7 2-(3-(2-(4-(4-Ethylpiperazin-1-yl)-3-fluorophenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)acetonitrile 
• 1239876-22-2 2-(3-(2-(3-fluoro-4-(4-ethylpiperazin-1-yl)phenylamino)-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)acetonitrile 
• 1580002-71-6 (E)-N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]-3-(4-nitrophenyl)acrylamide 
• 1580002-63-6 (E)-N-[4-(4-ethylpiperazin-1-yl)-3-fluorophenyl]cinnamamide 

Relevant academic research and scientific papers

Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives

The analogs of N-[4-(piperazin-1-yl)phenyl]cinnamamide were designed and synthesized by molecular hybridization approach in which part C of the designed molecule was linked through amide and carbamate functionality that improves the physicochemical properties and govern the pharmacokinetic and pharmacodynamic behavior. The systematic modification was done around the Part C to explore the structure activity relationship of antitubercular cinnamamide. All 52 compounds were evaluated for its antitubercular activity against Mycobacterium tuberculosis (M. tb) using Resazurin microtitre plate assay (REMA). Compound 11g with trifluoromethyl substitution exhibited good antitubercular activity of 3.125 μg/ml. The synthesized N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives showed promising activity against M. tb.

IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).

Pyrrolopyrimidinyl axl kinase inhibitors

Compounds represented by Formula (I): are useful in treating diseases, such as cancer, that are mediated and/or associated (at least in part) with Axl kinase. The compounds can be formulated as pharmaceutically acceptable compositions for administration t

N-(3,4-disubstituted phenyl) salicylamide derivatives

A compound represented by the following formula (I) or a salt thereof: wherein R1, R2, R3 and R4 represent hydrogen atom, a halogen atom, cyano group, nitro group, a C1-4 alkyl group, a halogenated C

PYRIMIDINYL ARYL UREA DERIVATIVES BEING FGF INHIBITORS

The invention relates to heteroaryl aryl ureas of the formula (IA), wherein the radicals and symbols have the meanings as defined herein, the use of such compounds in the treatment of protein kinase dependent diseases; to pharmaceutical preparations comprising said heteroaryl aryl ureas, to processes for the manufacture of such novel compounds and to methods of treatment comprising the use of such heteroaryl aryl ureas.

THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY

To provide thienopyrazole derivatives inhibiting PDE 7 selectively, and therefore, enhance cellular cAMP level. Consequently, the compound is useful for treating various kinds of disease such as allergic diseases, inflammatory diseases or immunologic diseases. The compound is thienopyrazole compound represented by the following formula (I): [wherein, especially, R 1 is a cyclohexyl, a cycloheptyl group or a tetrahydropyranyl group; R 2 is methyl; R 3 is a hydrogen atom; and R 4 is a group: -CONR 5 R 6 (in which any one of R 5 and R 6 is a hydrogen atom)].